Nido Biosciences
Watertown
About Nido Biosciences
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases. Nido Bio is developing solutions for severe neurological illnesses based on today's advances in neuroscience. The company creates precise medications using human genetics that treat the underlying biology of disease and restore healthy cell function.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $109.0M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2023)
- Website: nidobio.com
Industries & Categories
Biotechnology, Health Care, Neuroscience, Personal Health, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/nido-biosciences-22714 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.